Antianaerobic activity of moxifloxacin compared with that of ofloxacin, ciprofloxacin, clindamycin, metronidazole and β-lactams

被引:26
作者
Behra-Miellet, J
Dubreuil, L
Jumas-Bilak, E
机构
[1] Fac Pharm, F-59006 Lille, France
[2] Fac Pharm Montpellier, F-34060 Montpellier, France
关键词
anaerobic bacteria; moxifloxacin; antibiotic susceptibility;
D O I
10.1016/S0924-8579(02)00209-1
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Minimal inhibitory concentrations of moxifloxacin were compared with those of ofloxacin, ciprofloxacin, clindamycin, metronidazole and six beta-lactams for 159 anaerobes isolated from human clinical samples. Unlike other fluoroquinolones, moxifloxacin demonstrated high activity against the 76 strains of the Bacteroides fragilis group as the minimal inhibitory concentration(50) was 0.5 mg/l. Porphyromonas, Prevotella, Fusobacterium and Gram-positive anaerobic cocci were inhibited by 1 mg/l or less of moxifloxacin. It inhibited 93.7, 94.9 and 98% of the 159 strains investigated at concentrations of 1, 2 and 4 mg/l, respectively. Moxifloxacin was more potent than ofloxacin and ciprofloxacin against Gram-positive rods and anaerobic cocci. Its broad anaerobic spectrum in vitro is promising for the treatment of intra-abdominal and respiratory infections. (C) 2002 Elsevier Science B.V. and International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:366 / 374
页数:9
相关论文
共 10 条
[1]   Comparative activity of moxifloxacin in vitro against obligately anaerobic bacteria [J].
Ackermann, G ;
Schaumann, R ;
Pless, B ;
Claros, MC ;
Goldstein, EJC ;
Rodloff, AC .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2000, 19 (03) :228-232
[2]   Comparison of the in vitro activities of Bay 12-8039, a new quinolone, and other antimicrobials against clinically important anaerobes [J].
Aldridge, KE ;
Ashcraft, DS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (03) :709-711
[3]  
[Anonymous], NCCLS PUBL
[4]   Antianaerobic activity of grepafloxacin compared with ofloxacin, ciprofloxacin, clindamycin, metronidazole and 5 β-lactams [J].
Dubreuil, L ;
Singer, E ;
Odou, MF ;
Leblanc, F .
DRUGS, 1999, 58 (Suppl 2) :110-112
[5]   Antibacterial spectrum of a novel des-fluoro(6) quinolone, BMS-284756 [J].
Fung-Tomc, JC ;
Minassian, B ;
Kolek, B ;
Huczko, E ;
Aleksunes, L ;
Stickle, T ;
Washo, T ;
Gradelski, E ;
Valera, L ;
Bonner, DP .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (12) :3351-3356
[6]   Review of the in vitro activity of gemifloxacin against Gram-positive and Gram-negative anaerobic pathogens [J].
Goldstein, EJC .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 :55-65
[7]   Comparative in vitro activity of gemifloxacin [J].
King, A ;
May, J ;
French, G ;
Phillips, I .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 :1-12
[8]   Bay 12-8039, a new 8-methoxy-quinolone: comparative in-vitro activity with nine other antimicrobials against anaerobic bacteria [J].
MacGowan, AP ;
Bowker, KE ;
Holt, HA ;
Wootton, M ;
Reeves, DS .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (04) :503-509
[9]   Survey of anaerobic susceptibility patterns: A French multicentre study [J].
Mory, F ;
Lozniewski, A ;
Bland, S ;
Sedallian, A ;
Grollier, G ;
Girard-Pipau, F ;
Paris, MF ;
Dubreuil, L .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 1998, 10 (03) :229-236
[10]   In vitro activity of moxifloxacin against 179 strains of anaerobic bacteria found in pulmonary infections [J].
Wexler, HM ;
Molitoris, E ;
Molitoris, D ;
Finegold, SM .
ANAEROBE, 2000, 6 (04) :227-231